Angiogenesis Weekly
Susan Hasty, Publisher
Table of Contents . . . March 8th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Angiogenesis Weekly | Other Publications
Retinopathy - Blocking receptors could alleviate pathologic angiogenesis
Tumor Factors - Reduced levels of extracellular enzyme may actually promote cancer growth
Age-Related Macular Degeneration - Pain during verteporfin infusion may be more common than believed
Diagnostic Imaging - Contrast agent improves some aspects of visualizing tumor vascularity
Pancreatic Cancer - Inhibitor TIMP-1 a potential gene therapy target for cancer of pancreas
Antiangiogenesis - Drug target discovery alliance is expanded
Breast Cancer - Women with advanced disease sought for unique study at UCLA
Cancer Therapy - Retinoic acid might be of more harm than benefit to cancer patients
Drug Discovery - First milestone achieved in agreement for CD46 human antibodies against cancer
Gene Delivery - Company gains access to vectors of gene therapies that inhibit angiogenesis
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
